Remdesivir is killing people

[GURPS]

You can literally see the surge in 2020 of deaths due to the aggressive use of remdesivir. You can also see less but still the force on mortality of using liver and kidney toxic remdesivir.

Coquin de Chien does a tremendous job relaying the surge in deaths (all-cause deaths) in Massachusetts 2020, 2021, and 2022.

“CDC aggregates data into groups that often cause a Simpson’s Paradox, which obscures safety signals related to causes of death. For example, some researchers have shown “Renal failure” using codes “N17” through “N19.” Here are the individual codes in that range:

• N17.0 Acute renal failure with tubular necrosis
• N17.1 Acute renal failure with acute cortical necrosis
• N17.2 Acute renal failure with medullary necrosis
• N17.8 Other acute renal failure
• N17.9 Acute renal failure, unspecified
• N18.1 Chronic kidney disease, stage 1
• N18.2 Chronic kidney disease, stage 2
• N18.3 Chronic kidney disease, stage 3
• N18.4 Chronic kidney disease, stage 4
• N18.5 Chronic kidney disease, stage 5
• N18.9 Chronic kidney disease, unspecified
• N19 Unspecified kidney failure

‘Notice that “Acute” and “Chronic” kidney failure are lumped into that N17 to N19 range that the CDC offers. Even if someone died from a heart attack, and also had “N18.2” “Chronic kidney disease, stage 2” the death certificate will list N18.2 as one of the causes of death.”

Sudden kidney failure, known to doctors as acute renal failure (ARF) is a major health emergency in Massachusetts right now at this moment and likely in other US states, too. The Massachusetts Department of Public Health (MA DPH) may not even know about the excess 1,500 deaths that have occurred in the past 18 months.

Remdesivir is killing people & CDC & NIH & FDA & Fauci et al. DO NOT care; examines Massachusetts & sudden kidney failure, known to doctors as acute renal failure (ARF) is a major health emergency now

a great piece on the risk of remdesivir and I highlight it here, please share; to see how great this travesty is require separating the Renal failure category N17-N19 into its ICD-10 codes, e.g. N17.9

palexander.substack.com

 

[GURPS]

Remdesivir Increases Your Risk of Death. Dr. Paul Marik Speaks on the Deadly NIH Protocols and the Perverse Incentive Structure Driving this Mindless Approach in the Field.​

“Dr. Paul Marik testifies about the dangers of remdesivir and the corruption in our medical system for prescribing it. Though it is deadly, doctors are being incentivized to use it on patients.

Remdesivir killed more than 50% of the animals during its clinical trials. Yet the FDA still approved it.”

– Covid Vaccine News – Telegram Find More Here: https://t.me/CovidVaccineTruth
Dr. Paul Marik, FLCCC

 

[GURPS]

The Strange Story Of Remdesivir, A Covid Drug That Doesn’t Work​

Remdesivir is not effective for Covid​

News media prematurely reported that patients were responding to treatment.

But the published data lated showed that "remdesivir was not associated with statistically significant clinical benefits [and] the numerical reduction in time to clinical improvement in those treated earlier requires confirmation in larger studies."


The controversy surrounding remdesivir therefore revolves around whether the drug is actually an effective treatment.

Early studies produced conflicting evidence on remdesivir's effectiveness. Some found that Covid patients who received the drug recovered faster and fewer people died, but other studies showed that it didn't reduce the length of hospitalization or death rate.

What's weird about remdesivir is that it hasn't been held to the same standards as other drug candidates.

Covid-19 vaccines have been developed 10 times faster than traditional drugs, but they've passed the phase-3 clinical trials that test whether a potential medicine is both safe and effective in thousands of people.

 

[GURPS]

Fauci successor at NIAID peddled dangerous Remdesivir drug as 'silver bullet' against Covid-19​

Prior to moving to her Government Health post, Marrazzo was the longtime director of the Division of Infectious Diseases at the University of Alabama at Birmingham (UAB).

In partnership with Big Pharma drugmaker Gilead, UAB played a major role in the research and development of Remdesivir. The drug was developed over a decade ago with the hopes to treat Hepatitis C and respiratory syncytial virus (RSV), but was suddenly repurposed to “treat” Covid-19 when coronavirus hysteria reached the United States.

Given the UAB-Gilead partnership, one would think that Dr. Marrazzo would refrain from commenting on issues through which she maintained a clear conflict of interest. Or at the very least, she had the duty to disclose her conflict of interest when speaking to the media about the UAB-developed “wonder drug.” She did no such thing.



Even worse, Dr. Marrazzo bashed harmless and low cost alternatives like hydroxychloroquine, while hyping the super expensive Gilead-UAB competitor drug.

“The hope was maybe, if you treat early in the disease, you don’t need a silver bullet” such as remdesivir, she told The Washington Post in a July 2020 piece. “Hospitals are on the razor’s edge,” she added, contributing to the fear and paranoia that was enveloping the nation at the time.

In interview after interview, Dr. Marrazzo had nothing but good things to say about remdesivir, despite the incredible lack of data available to support her outandish claims about the drug.

On social media, Marrazzo lavished endless praise upon Remdesivir, declaring it the best agent against coronavirus disease, and boasting that her hospital tries to use it on every covid-hospitalized patient.

“We don’t have enough remdesivir to treat everybody who’s in the hospital,” she said in a late 2020 news conference about the state of her hospital system. “It’s a really challenging situation.”

Her predecessor at the NIAID, Mr Fauci, infamously paraded Remdesivir as the “standard of care” for Covid-19 treatment, adding that it can “block the virus.”

Unsupported pseudoscientific claims about very expensive drugs (a full course of remdesivir costs the patient thousands of dollars) is nothing new for NIAID officials, who, under Fauci’s leadership, have created an agency that acts as a government marketing department for pharmaceutical companies.

Undoubtedly, Marrazzo’s Remdesivir maximalism had disastrous implications for patients hospitalized at UAB. The so-called silver bullet later took on a morbid nickname, “run, death is near,” because of the severe side effect portfolio associated with the IV drug.